Variant report
Variant | nsv514288 |
---|---|
Chromosome Location | chr5:7917042-7919114 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:7913593..7916151-chr5:7918931..7921579,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2126104 | chr5:7917044-7917045 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs548152703 | chr5:7917068-7917069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs568376570 | chr5:7917085-7917086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs142434421 | chr5:7917132-7917133 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116357701 | chr5:7917133-7917134 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs2388771 | chr5:7917137-7917138 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs575498736 | chr5:7917149-7917150 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs540079828 | chr5:7917173-7917174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs553686891 | chr5:7917203-7917204 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183194807 | chr5:7917204-7917205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370169757 | chr5:7917214-7917215 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs555303775 | chr5:7917251-7917252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs187490917 | chr5:7917309-7917310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs575135950 | chr5:7917350-7917351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs12186809 | chr5:7917360-7917361 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs150901748 | chr5:7917361-7917362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs577755489 | chr5:7917400-7917401 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs191988608 | chr5:7917436-7917437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs559939525 | chr5:7917516-7917517 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs574793447 | chr5:7917534-7917535 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529119922 | chr5:7917571-7917572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs12189183 | chr5:7917580-7917581 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
23 | rs183378006 | chr5:7917601-7917602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530854375 | chr5:7917737-7917738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76231165 | chr5:7917739-7917740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs145532675 | chr5:7917741-7917742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs147807567 | chr5:7917767-7917768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs141197386 | chr5:7917781-7917782 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567081157 | chr5:7917813-7917814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs187759577 | chr5:7917836-7917837 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs192463357 | chr5:7917839-7917840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs540424280 | chr5:7917882-7917883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs162273 | chr5:7917934-7917935 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs28829123 | chr5:7917953-7917954 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs148099112 | chr5:7917989-7917990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lung cancer | 21911935 | CNVD |
Cri-du chat syndrome | 21549014 | CNVD |
Cervical squamous cell carcinoma | 21590768 | CNVD |
Melanoma | 18172304 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
renal disease | 17924346 | CNVD |
abnormal development | 18461090 | CNVD |
Lung cancer | 19547694 | CNVD |
Cri-du chat syndrome | 22283845 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Cancer | 21183584 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Cancer | 16751803 | CNVD |
Breast cancer | 17133270 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Liposarcoma | 21253554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Oral cancer | 21386901 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Cervical cancer | 18559093 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Developmental delay | 21147756 | CNVD |
prenatal diagnosis | 22389664 | CNVD |
Bladder cancer | 21909424 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Breast cancer | 21858162 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Melanoma | 22183965 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Autism | 22495311 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 16608533 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Cancer | 22183965 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Intellectual disability | 22102821 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Ependymoma | 20639864 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:7909800-7917600 | Weak transcription | Rectal Mucosa Donor 31 | rectum |
2 | chr5:7915400-7917200 | Enhancers | Osteobl | bone |
3 | chr5:7917600-7918000 | Enhancers | Rectal Mucosa Donor 31 | rectum |